We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Tissue Sealer Improves Efficiency During Laparoscopic Procedures

By HospiMedica International staff writers
Posted on 04 Mar 2014
A new open jaw vessel sealer and divider allows surgeons to grasp, seal, and cut tissue with minimal steps and reduced instrument exchanges.

The LigaSure Maryland Jaw combines energy-based vessel sealing technology with the functionality of three common surgical tools - a Maryland dissector, which is a blunt surgical tool with a curved jaw used to separate, grasp and manipulate tissue; an atraumatic tissue grasper; and cold surgical scissors. The device is designed for use in minimally invasive procedures including urologic, vascular, thoracic and thoracoscopic, and gynecologic procedures where ligation and division of the vessels is performed.

Image: The LigaSure Maryland Jaw open jaw vessel sealer and divider (Photo courtesy of Covidien).
Image: The LigaSure Maryland Jaw open jaw vessel sealer and divider (Photo courtesy of Covidien).

The vessel sealing technology is powered by proprietary ForceTriad energy platform, controlled by TissueFect sensing technology, which monitors changes in tissue 3,333 times per second, adjusting energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect. The technology uses the body’s own collagen and elastin to create a permanent fusion zone, including vessels up to and including 7 mm in diameter, lymphatics, tissue bundles, and pulmonary vasculature.

The LigaSure Maryland jaw device is a product of Covidien (Dublin, Ireland) and comes in three lengths; a 37 cm version, which will be available in early 2014, and 23 cm and 44 cm options which will be available later in the year. The LigaSure Maryland jaw device has received the approval of the US Food and Drug Administration (FDA), as well as completing all European community requirements to receive the CE marking of approval.

“For more than 15 years, surgeons have trusted LigaSure technology for its ability to reduce blood loss, shorten procedure time, and shorten the length of hospital stay compared to sutures,” said Chris Barry, president of advanced surgical devices at Covidien. “The LigaSure Maryland jaw offers surgeons an efficient, versatile, and multifunctional option for one-step sealing and further demonstrates Covidien’s commitment to expand energy device options with solutions targeted at specific procedures and surgeon use needs.”

Related Links:

Covidien



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Latest Surgical Techniques News

Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries

Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant

Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment